Close Menu
Home › Bio-Techne, Lisen Partner on MDx Products for Chinese Market

Bio-Techne, Lisen Partner on MDx Products for Chinese Market

Feb 26, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Bio-Techne today announced a strategic agreement with China's Lisen Imprinting Diagnostics Wuxi in the field of precision medicine.

Specifically, the partnership, Minneapolis-based Bio-Techne said, will accelerate the development of molecular diagnostics in the Chinese market. Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
10
Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Molecular Diagnostics

  1. Roche Gains FDA Clearance for Cobas Babesia Blood Test

  2. Germany's Publicly Funded Insurance to Cover NIPT Under Limited Circumstances

  3. HTG Molecular Diagnostics Prices $20M in Stock Offerings

  4. Oncimmune Scottish Study Results Could Fuel Move Into Screening as Firm Eyes CDx Opportunities

    Premium

  5. Chinese Infectious Disease Dx Firm Vision Medicals Raises $14M in Series A Round

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.